4th International Medical Cannabis Conference

Start:
Sep 9, 2019, 9:00 AM
End:
Sep 10, 2019, 5:30 PM

About 4th International Medical Cannabis Conference

Your access to the most relevant developments, innovations, and opportunities in medical cannabis

A rapidly growing and evolving field, medical cannabis is taking center-stage for scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders around the globe. First-hand knowledge and networks are essential in understanding the way forward within this complex ecosystem. CannX is the ultimate place to gain a deep understanding of what is truly ground-breaking in research, business, agriculture and technology. It is where connections are formed, ideas are exchanged, and opportunities move forward.

Features

Three Dynamic Tracks
Explore sessions from three dynamic tracks, covering the full-range of topics essential for all leaders in today’s medical cannabis scene.

SCI
Access the cutting-edge science driving the next wave of developments. Noted researchers and practitioners will present their latest findings.

BIZ
Gain unparalleled insight into the future of business for local and global markets. We will delve into opportunities, pitfalls and the how-to for smart-investments in medical cannabis.

AGR
Stay ahead of competition as the world supply chain develops. CannX will feature new technology, systems and solutions designed to help farmers succeed.

Speakers

Yossi Bornstein
Chairman and CEO of Shizim Group
Heli Dangur
Director of Global Business Development Cann10
Abigail Dar
Founder of CannaFora, Israel
Perry Davidson
Founder and CEO Syqe Medical
Abraham J. Domb
Phd. Cannabinoids Research Multidisciplinary Center, Hebrew University of Jerusalem, Israel
Michael Dor
Senior Medical Advisor Medical Cannabis Unit, Cannatech, Israel
View More (41)
Orna Dreazen
CEO & Chairperson of the board Nextar Chempharma Solutions
Ziva Eger
Chief Executive of Foreign Investments & Industrial Co-operation
Andrea S Heimann
CEO Proteimax and Pepticana, Brazil
Arnon Heyman
Saul Kaye
Founder and CEO Israel-Cannabis
Zohar Levy
Co-Founder, CEO, Chairman Seedo
Gilad Livni
Cannabis Consulted Breeder, Israel
Jonathan Page
Chief Science Officer Canada Aurora Cannabis Inc.
Shay Avraham Sarid
Co-Founder & CTO Seach
Gurmit Singh
Professor, Pathology and Molecular Medicine, Singh laboratory, McMaster University, Canada
Orit Stolar
Pediatric Neurologist, Assaf Harofeh Medical Center, Israel
Boaz Wachtel
Hagit Weinstock
Partner in Weinstock-Zehavi Law Offices, Israel
Ma'ayan Weisberg Joels
Business Development Manager Tikun Olam LTD
David Casarett
Professor of Medicine, Duke University/Duke Health, USA
LUMIR HANUS
Chief Scientist, Asana Bio Group Ltd
Philippe Lucas
VP, Global Patient Research & Access, Tilray Social Dimensions of Health
Raphael Mechoulam
Prof., Institute for Drug Research, The Hebrew University of Jerusalem
Andreas Zimmer
Prof., Director, Institute of Molecular Psychiatry University of Bonn, Germany
Adi Aran
Director of the Neuro-pediatric unit, Shaare Zedek Medical Center, Jerusalem, Israel
Simon Benita
Professor at Hebrew University of Jerusalem
NIRIT BERNSTEIN
Department Head, Soil Physics and Irrigation, Institute of Soil, Water and Environmental Sciences Volcani Center, Israel
Elyad Davidson
Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel
Ruth Djaldetti
Movement Disorder Clinic, Department of Neurology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel
Shiry Eden
CEO at Nisot Strategy
Clifton Flack
Founder at CiiTECH, Israel
Nissim Garti
Professor of Chemistry at Hebrew University
DR JONATHAN GRUNFELD
Palliative Care, Asaf Harofeh Medical Center, Israel
Steve Hawkins
President and CEO of Horizons ETFs, Canada
Vered Hermush
Medical Director Geriatric Wing, Laniado Hospital, Israel
Itzhak Kurek
CEO and co-founder of Cannformatics
Shaul Lev-Ran
Deputy Director, Lev Hasharon Medical Center
DAVID MEIRI
Head of Scientific Advisory Board Assistant Professor, Heads the `Laboratory of Cancer Biology and Cannabinoid Research` Technion, Institute of Technology, Israel
Gal Meiri
Head of Preschool Psychiatric Unit Soroka Medical Center, Ben Gurion University of the Negev, Israel
Victor Novack
Head of Soroka Clinical Research Center, Israel
Reuven Or
Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel
Avi Priel
Prof., Head, Ion Channels Biophysics and Pharmacology Laboratory Chair, Pharmacology Section, The Multidisciplinary Center for Cannabinoid Research, Israel
Kevin Roland
Avner Shenfeld
Epigenetics Ltd., Israel
Yossi (Joseph) Tam
Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
Rami Yaka
Chair in Psychopharmacology Head, Program for Advance Studies School of Pharmacy, The Institute for Drug Research (IDR) Faculty of Medicine, The Hebrew University of Jerusalem, Israel

Sponsors

Cannassure
Mary’s Medicinals
Tikun Olam LTD
Strainprint
Tetra Bio-Pharma Inc.
GemmaCert
International Medical Cannabis
Provacan
View More (6)

Partners

Canopy Growth
Tilray
AuroraMJ PRO
Cannformatics
Medical Cannabis and Cannabinoids
Israel Advanced Technology Industries
Tel Aviv University
Cannabis Outcomes LLC
View More (3)
INFUZES